Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Celgene Corp.
Current Parent Company: Bristol-Myers Squibb
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $20,700,000
Year: 2017
Date: July 24, 2017
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Violation Description: Celgene Corp. agreed to pay $20.7 million to settle multistate litigation alleging it caused false claims to be submitted to state Medicaid programs by promoting two cancer treatment drugs for uses not approved by the Food and Drug Administration. This was part of a larger $280 million settlement involving the federal government; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: New York
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.